Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

AstraZeneca PLC

AZNCFPNK
Healthcare
Drug Manufacturers - General
$204.20
$-4.42(-2.12%)
U.S. Market opens in 8h 20m

AstraZeneca PLC (AZNCF) Stock Overview

Explore AstraZeneca PLC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap316.6B
P/E Ratio30.75
EPS (TTM)$6.03
ROE0.23%
Fundamental Analysis

AI Price Forecasts

1 Month$192.55
3 Months$200.27
1 Year Target$174.26

AZNCF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AstraZeneca PLC (AZNCF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 68.74, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $174.26.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 30.75 and a market capitalization of 316.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.12%
5-Day Change
N/A
1-Month Change
15.04%
3-Month Change
11.84%
6-Month Change
29.99%
Year-to-Date (YTD) Change
11.78%
1-Year Change
37.96%
3-Year Change
51.55%
5-Year Change
107.02%
All-Time (Max) Change
411.78%

Contact Information

44 20 3749 5000
1 Francis Crick Avenue, Cambridge, NaN, CB2 0AA

Company Facts

943,000 Employees
IPO DateFeb 13, 2009
CountryGB
Actively Trading

Frequently Asked Questions